JP2002512614A - 化学的かつ熱的に安定なノルアステミゾール製剤 - Google Patents

化学的かつ熱的に安定なノルアステミゾール製剤

Info

Publication number
JP2002512614A
JP2002512614A JP54589398A JP54589398A JP2002512614A JP 2002512614 A JP2002512614 A JP 2002512614A JP 54589398 A JP54589398 A JP 54589398A JP 54589398 A JP54589398 A JP 54589398A JP 2002512614 A JP2002512614 A JP 2002512614A
Authority
JP
Japan
Prior art keywords
norastemizole
pharmaceutically acceptable
lactose
pharmaceutical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP54589398A
Other languages
English (en)
Japanese (ja)
Inventor
レドモン，マーティン，ピー．
バルター，ハル，ティー．
ワルド，ステファン，エイ．
Original Assignee
セプラコア インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セプラコア インコーポレーテッド filed Critical セプラコア インコーポレーテッド
Publication of JP2002512614A publication Critical patent/JP2002512614A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP54589398A 1997-03-26 1998-03-25 化学的かつ熱的に安定なノルアステミゾール製剤 Pending JP2002512614A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US82447797A 1997-03-26 1997-03-26
US08/824,477 1997-03-26
US85178697A 1997-05-06 1997-05-06
US08/851,786 1997-05-06
PCT/US1998/005701 WO1998042379A2 (en) 1997-03-26 1998-03-25 Chemically and thermally stable norastemizole formulations

Publications (1)

Publication Number Publication Date
JP2002512614A true JP2002512614A (ja) 2002-04-23

Family

ID=27124816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54589398A Pending JP2002512614A (ja) 1997-03-26 1998-03-25 化学的かつ熱的に安定なノルアステミゾール製剤

Country Status (13)

Country Link
EP (1) EP1035869A1 (ru)
JP (1) JP2002512614A (ru)
KR (1) KR20010005746A (ru)
CN (1) CN1257431A (ru)
AR (1) AR012187A1 (ru)
BR (1) BR9808428A (ru)
CA (1) CA2284705A1 (ru)
HU (1) HUP0001823A3 (ru)
NO (1) NO994655L (ru)
NZ (3) NZ517472A (ru)
RU (1) RU2214245C2 (ru)
WO (1) WO1998042379A2 (ru)
ZA (1) ZA982562B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013502452A (ja) * 2009-08-24 2013-01-24 アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ オチロニウムの直接圧縮錠

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289261B6 (cs) 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
EP2201982A1 (en) * 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3781173T2 (de) * 1986-02-03 1992-12-17 Janssen Pharmaceutica Nv N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen.
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4394931T1 (de) * 1992-09-03 1995-07-20 Sepracor Inc Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
PT920425E (pt) * 1995-11-17 2003-07-31 Aventis Pharma Inc 4-(1h-benzimidazol-2-il-amino)piperidinas substituidas uteis para o tratamento de doencas alergicas
EP0920315B1 (en) * 1996-08-16 2005-12-28 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013502452A (ja) * 2009-08-24 2013-01-24 アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ オチロニウムの直接圧縮錠

Also Published As

Publication number Publication date
HUP0001823A3 (en) 2002-04-29
RU2214245C2 (ru) 2003-10-20
WO1998042379A3 (en) 2001-03-01
NO994655D0 (no) 1999-09-24
CN1257431A (zh) 2000-06-21
ZA982562B (en) 1998-10-01
NZ517472A (en) 2003-08-29
HUP0001823A2 (hu) 2001-04-28
AU6868098A (en) 1998-10-20
EP1035869A1 (en) 2000-09-20
BR9808428A (pt) 2000-05-23
CA2284705A1 (en) 1998-10-01
AR012187A1 (es) 2000-09-27
NO994655L (no) 1999-11-15
AU735257B2 (en) 2001-07-05
NZ527200A (en) 2004-12-24
KR20010005746A (ko) 2001-01-15
NZ527201A (en) 2004-12-24
WO1998042379A2 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
EP0969836B1 (en) Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
JP4435424B2 (ja) 口腔内で速やかに崩壊する錠剤
JP4802436B2 (ja) 口腔内崩壊型組成物及び口腔内崩壊型製剤
RU2153337C2 (ru) Таблетка парацетамола и домперидона с пленочным покрытием
JP2002509882A (ja) フルオキセチンおよびそのエナンチオマーの安定した投薬剤形
EP4082534A1 (en) Solid preparation, and preparation method therefor and use thereof
US20060240101A1 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
JP2001513801A (ja) パラセタモールを含む嚥下錠剤
JP2000119175A (ja) 口腔内速崩壊性固形製剤
RU2694056C2 (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
US20020173522A1 (en) Pharmaceutical compositions comprising norastemizole
JP2002512614A (ja) 化学的かつ熱的に安定なノルアステミゾール製剤
WO2003075919A1 (fr) Comprime contenant du chlorhydrate de pilsicainide (voie seche)
AU735257C (en) Chemically and thermally stable norastemizole formulations
RU2707286C1 (ru) Фармацевтическая противогрибковая композиция на основе производного хлорфенилбутандиона и способ её получения
JP4393119B2 (ja) ヨウ化イソプロパミド含有製剤
AU776837B2 (en) Lactose-free non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
MXPA99008710A (en) Chemically and thermally stable norastemizole formulations
CZ340699A3 (cs) Farmaceutický prostředek s obsahem norastemizolu
AU2011236040A1 (en) (R,R)-Formoterol in combination with other pharmacological agents